Our Work

Our research found that social stigma perceptions were more common in type 1 diabetes than type 2, possibly because type 2 is less visible.

Our research reveals low awareness of DKA and ketone testing among type 2 diabetes patients on SGLT2 inhibitors, highlighting urgent education needs.

dQ&A presented three research abstracts at ATTD 2025, an academic and professional conference of innovation and advancement in diabetes devices.